286: RSV Fusion Glycoprotein

Author: David S. Goodsell
RSV Fusion Glycoprotein

Structures of the fusion glycoprotein from respiratory syncytial virus (RSV) were used to engineer effective vaccines to fight viral infection.

For more details, please refer the original article in PDB-101 of RCSB PDB.

This is an mirror page of the "Molecule of the Month" article provided in PDB-101 of the RCSB PDB. This article was released on October 2023. To reprinting and citation, please refer our terms and conditions page. 

	{
    "header": {
        "minimamHeightScale": 1.0,
        "scalingAnimSec": 0.3
    },
    "src": {
        "spacer": "/share/im/ui_spacer.png",
        "dummy": "/share/im/ui_dummy.png"
    },
    "spacer": "/share/im/ui_spacer.png"
}